×

ROCHE CANCER DRUG ZELBORAF FAILS IN PHASE III ADJUVANT MELANOMA STUDY

ROCHE CANCER DRUG ZELBORAF FAILS IN PHASE III ADJUVANT MELANOMA STUDY